New hope for stubborn Behçet's sores? drug trial seeks relief
NCT ID NCT05449548
Summary
This study is testing if a drug called lenalidomide can help heal painful mouth and genital sores in adults with Behçet's syndrome who haven't responded well to standard treatments. It will involve 42 participants who will take the drug daily for 12 weeks. The main goal is to see if the sores completely disappear and to monitor the drug's safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.